Di-Iodohydroxyquinoline

Di-iodohydroxyquinoline used in the treatment of amebiasis (dysentery) and also as an skin antiseptic.

Di-Iodohydroxyquinoline is primarily indicated in conditions like Amoebiasis, Amoebic liver abscess, Giardiasis.

Di-Iodohydroxyquinoline is contraindicated in conditions like Thyroid disease, Blood dyscrasias, Optic neuropathy, Nervous disorders.

The severe or irreversible adverse effects of Di-Iodohydroxyquinoline, which give rise to further complications include Hair loss, Thrombocytopenia, Dermatitis, Neutropenia. The symptomatic adverse reactions produced by Di-Iodohydroxyquinoline are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Drowsiness, Ataxia, Nausea, Vomiting, Diarrhea, Urticaria, Pruritus, Dysuria, Polyuria, Metallic taste, Cystitis, Abdominal discomfort.

Di-iodohydroxyquinolone should be used with caution in patients with thyroid disease. Avoid use in patients with neurological disorder, impaired kidney or liver function, and hypersensitive to iodine or halogenated hydroxyquinolon. Discontinue treatment if abnormal neurologic signs appear.

Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

650 mg (650 (650)) 8 hourly PO — For 15-20 Days

No child dosage information is recorded for this medicine yet.

No neonatal dosage information is recorded for this medicine yet.

No data regarding the interactions of Di-Iodohydroxyquinoline was found.

Tab